Results 111 to 120 of about 5,279 (163)

An integrated molecular approach for the detection and species-level identification of <i>Leishmania</i> spp. in clinical samples. [PDF]

open access: yesMicrobiol Spectr
Risso MG   +11 more
europepmc   +1 more source

Cutaneous Leishmaniasis in Patients under Biologic Therapies: A Spanish CLINI-AEDV Multicentre Study. [PDF]

open access: yesActa Derm Venereol
Ciudad A   +27 more
europepmc   +1 more source

Therapeutic challenges in relapsing cutaneous and visceral leishmaniasis caused by Leishmania (Mundinia) martiniquensis in patients with advanced HIV disease from Southern Thailand. [PDF]

open access: yesTrop Med Health
Phadungsaksawasdi K   +11 more
europepmc   +1 more source

Fifteen-Year Evolution of Chronic Cutaneous Leishmaniasis Mimicking Other Dermatoses. [PDF]

open access: yesAm J Trop Med Hyg
Hurtado-Rossi L   +3 more
europepmc   +1 more source

Cutaneous and Mucocutaneous Leishmaniasis

open access: yesActas Dermo-sifiliográficas, 2021
Leishmaniasis is a chronic disease caused by flagellate protozoa of the genus Leishmania. It is a global disease, but most cases are seen in South America, the Mediterranean, and some areas of Asia and Africa. The 3 main types of leishmaniasis are cutaneous (the most common), mucocutaneous, and visceral (the most severe). Visceral leishmaniasis is also
Isabel Abadías-Granado   +2 more
exaly   +7 more sources

Cutaneous and Mucocutaneous Leishmaniasis

Infectious Disease Clinics of North America, 2012
Tegumentary leishmaniases are caused by approximately 15 species of protozoa of the genus Leishmania. They prevail in tropical and subtropical areas of the Old and New World but human mobility also makes them a medical problem in nonendemic areas. Clinical manifestations may comprise cutaneous and mucocutaneous forms that may be localized, disseminated,
Hiro Gotō, Lindoso Jal
exaly   +3 more sources

Home - About - Disclaimer - Privacy